SOMERSET, N.J., March 26, 2010 (GLOBE NEWSWIRE) -- inVentiv Health, Inc. (Nasdaq:VTIV) announced today that is has been approached by financial investors regarding a possible acquisition of the company. To consider possible courses of action, inVentiv has formed a special committee of the Board of Directors, which has retained Goldman, Sachs & Co. as a financial advisor. inVentiv does not expect to make further comments about this matter unless it enters into a definitive agreement. There can be no assurance that inVentiv will enter into any transaction.
About inVentiv Health
inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.
No comments:
Post a Comment